DNA X, Inc.
SONM· Nasdaq
SONMDNA X, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001564590-20-053411
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $14.39M | $28.85M | $39.50M |
| Net Income | -$6.46M | -$6.77M | $2.13M |
| EPS Diluted | -$0.98 | -$0.33 | -$0.91 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
